July 14, 2024


The business lovers

Atos and Huma enter into five-year partnership to improve healthcare and research with innovative remote monitoring technologies

Paris (France), 3 June 2021

Atos and Huma, the electronic wellness innovator, have announced a five-12 months strategic world wide partnership to change health care and clinical trials from medical center to dwelling. The partnership will target on Huma’s modular platform which can ability electronic ‘hospitals at home’ up to nationwide scale, as nicely as help pharmaceutical and exploration industries to operate advanced world wide decentralized clinical trials. The platform is previously utilised in the US and throughout Europe for ailments ranging from atrial fibrillation to diabetic issues to Covid-19.

Atos will use its encounter in applying and scaling advanced transformation tasks to speed up adoption of Huma’s technological innovation. This will incorporate financial commitment by Atos value up to €20 million split throughout R&D and go-to-marketplace resources, like committed consulting and profits personnel. The financial commitment in R&D will speedy-keep track of the integration of the Huma platform with other main clinical platforms, as nicely as produce a committed movie module.

The immense force exerted by the Covid-19 pandemic on the world’s health care techniques uncovered the weaknesses of existing versions previously overstretched with ageing populations and the increasing world wide incidence of continual problems. Innovation is desired to improve both of those patient treatment and the overall performance of the treatment chain. Atos and Huma’s solution signifies patients are monitored exterior of medical center and given timely, proactive clinical intervention in advance of will need, eventually optimizing the use of resources, strengthening patient results and lessening extended-expression health care costs. Early stage proof has demonstrated Huma’s support, which has previously been running nationally throughout Germany, England and the UAE, can just about double medical center ability.

Robert Vassoyan, Head of Health & Daily life Sciences organization, Atos, reported: “We have fantastic pleasure about this partnership, as we are persuaded that Atos and Huma can generate a systemic change from reactive to proactive versions of treatment. Huma is the corporation we have been wanting for in this critical mission that resonates with every single of us personally as we search for to improve the life of our family members, pals, neighbors and modern society. This is a partnership worthy of the mission.”

Dan Vahdat, CEO and Founder of Huma, reported: “This partnership normally takes us to a new league – we have previously demonstrated that we can generate a support for a new disease region in a make a difference of months, as we did all through the pandemic, and that we can go stay with in excess of one hundred clinics in a working day. Atos will supercharge our work so we can offer you products and services at scale, any where in the environment throughout supply of treatment and pharma collaborations main to more folks living lengthier, fuller life.”

The partnership will advantage from Huma’s course-main software program platform and forty+ patents, and Atos’ intensive specialist support knowledge in electronic approach, adjust management and support management.

The five-12 months partnership will start with integration, enabling world wide go-to-marketplace deployments, but will also combine Atos’s knowledge of driving electronic adoption, help and infrastructure with Huma’s electronic treatment, clinical trials and biomarkers. The companies conservatively hope the merged support will attain €100m revenue for each 12 months inside the initial four several years.

Down load the release in pdf


About Atos

Atos is a world wide chief in electronic transformation with one zero five,000 employees and annual revenue of in excess of € 11 billion. European number a person in cybersecurity, cloud and significant performance computing, the Team supplies tailored conclusion-to-conclusion solutions for all industries in seventy one nations around the world. A pioneer in decarbonization products and services and products and solutions, Atos is dedicated to a protected and decarbonized electronic for its consumers. Atos operates underneath the manufacturers Atos and Atos|Syntel. Atos is a SE (Societas Europaea), listed on the CAC40 Paris inventory index.

The function of Atos is to help structure the long term of the info area. Its knowledge and products and services help the enhancement of know-how, instruction and exploration in a multicultural solution and add to the enhancement of scientific and technological excellence. Across the environment, the Team allows its prospects and employees, and members of societies at big to stay, work and produce sustainably, in a risk-free and protected info area. www.atos.net

About Huma

Huma is a world wide wellness technological innovation corporation that allows folks stay lengthier, fuller life. Our modular platform supports electronic ‘hospitals at home’ throughout different disease spots. In existence sciences we ability some of the world’s greatest decentralized clinical trials and studies. Our platform combines artificial intelligence, electronic biomarkers and authentic-environment information to advance proactive, predictive treatment and exploration.

Our ‘hospitals at home’ help treatment for patients throughout the England NHS, Wales, Germany, and the UAE — proof demonstrates they can double clinical ability, lessen readmission premiums by a 3rd, and lessen costs whilst giving risk-free, significant-good quality treatment. We offer you Covid-19 electronic products and services, not-for-earnings, to nationwide governments to help fight against the pandemic and have delivered in excess of a million gadgets that enhance our ‘hospitals at home’ to help ability them. www.huma.com

Press contacts

Atos: Marion Delmas | [email protected] | +33 6 37 63 91 ninety nine

Huma: Sian Jarvis, [email protected] | Ed Sykes, [email protected]